A nuclear SH3 domain-binding protein that colocalizes with mRNA splicing factors and intermediate filament-containing perinuclear networks by Craggs, G. et al.
A Nuclear SH3 Domain-binding Protein That Colocalizes with
mRNA Splicing Factors and Intermediate Filament-containing
Perinuclear Networks*
Received for publication, April 9, 2001
Published, JBC Papers in Press, May 25, 2001, DOI 10.1074/jbc.M103142200
Graham Craggs‡§, Peter M. Finan‡§¶, Durward Lawson, Jonathan Wingfield‡, Timothy Perera‡,
Smita Gadher‡, Nicholas F. Totty**, and Stuart Kellie‡ ‡‡
From the ‡Yamanouchi Research Institute, Littlemore Park, Oxford OX4 4XS, the Department of Molecular Pathology,
Windeyer Bldg., University College Medical School, London W1, and the **Ludwig Institute for Cancer Research,
University College London, 91 Riding House St., London W1P 8BT, United Kingdom
A protein (SNP70) has been isolated that binds to the
Src homology domain 3 of p47phox, p85, and c-src. Clon-
ing and sequencing of the polypeptide revealed it to be a
70-kDa protein that has a number of potential domains,
including Src homology 3 binding motifs and several
nuclear localization signals. Immunofluorescence using
anti-peptide antibodies revealed SNP70 to be primarily
concentrated in the nucleus but excluded from nucleoli,
in interphase cells. However, it was distributed through-
out the cytoplasm in dividing cells. Extraction and sub-
fractionation experiments indicated that SNP70 did not
bind directly to DNA but did bind to poly(G)-rich oligo-
nucleotides and was resistant to extraction with non-
ionic detergents but was solubilized by treatment with
RNase, high salt, or ammonium sulfate. Double-immun-
ofluorescence experiments showed that SNP70 co-local-
ized with two pre-mRNA splicing factors SC35 and U2B
within the nucleus. A population of SNP70 was found
outside the nucleus, and double-immunofluorescence
and immunoelectron microscopy demonstrated that it
associated with vimentin-containing intermediate fila-
ments, particularly those surrounding the nucleus. The
data suggest that SNP70 associates with nuclear or pe-
rinuclear filaments and may play a role in the regula-
tion of pre-mRNA processing.
Intermolecular associations are essential for the generation
of intracellular signals resulting from activation stimuli at the
plasma membrane. A number of modular domains have now
been described that mediate these interactions, and sequence
homologies have indicated that these domains are widespread
in signaling molecules. Examples of domains that are respon-
sible for intracellular associations of signaling molecules in-
clude pleckstrin homology (PH)1 domains, Src homology 2
(SH2) domains, and Src homology 3 (SH3) domains (1, 2).
PH domains are regions of about 100 amino acids, usually of
low homology, that associate with small hydrophobic moieties
such as inositol phospholipids, and it has been proposed that
PH domains are a mechanism for targeting proteins to mem-
branes (3–5).
SH2 domains are regions of about 100 amino acids that bind
to specific phosphotyrosine-containing peptide sequences (6–
8). Ligation of receptors at the cell surface results in the for-
mation of complexes consisting of specific intracellular signal-
ing molecules (9–11), and therefore SH2 domains appear to
target molecules to the plasma membrane by binding to pro-
teins that contain phosphotyrosine. NMR studies and x-ray
crystallography have revealed detailed structures of a number
of SH2 domains, and all consist of two anti-parallel  sheets
surrounded by two -helices, with the phosphotyrosine and
3 residue tightly bound to two pockets on the domain surface
(12).
SH3 domains are regions of about 50–75 amino acids, which
are also commonly found in signaling molecules, in cytoskeletal
components, and in the phagocyte superoxide-forming complex,
the NADPH oxidase. Many proteins that contain PH and SH2
domains also contain an SH3 domain, however, there are sub-
sets of proteins that can have several permutations or multi-
ples of these domains. SH3 domains bind to proline-rich se-
quences with a core motif of PXXP, where P are conserved
proline residues and X are commonly aliphatic (13). Although
there is some promiscuity in the binding of some SH3 domains
to different proline-rich motifs (14) other SH3 domains are
highly selective and will bind to only a single specific sequence
(15, 16). All SH3 domain ligands adopt a type II polyproline
helix conformation, and structural studies have shown that
proline-rich motifs fall into two classes, which can bind to SH3
domains in either forward or reverse orientations (17–24). The
activation of the phagocyte NADPH oxidase is regulated by the
SH3 domain-mediated assembly of cytosolic components with a
membrane protein complex containing a proline-rich SH3 do-
main binding site (25). Although it is well recognized that
regulation of SH2 domain interactions occurs by phosphoryla-
tion, the regulation of SH3 domain interactions is less well
understood and is probably at the level of conformational
changes leading to masking or unmasking of the domain or its
ligand.
In an attempt to identify novel SH3-binding proteins that
might be involved in intracellular signaling we have attempted
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to isolate SH3 domain-containing proteins from cells. This re-
port describes the identification and cloning of a proline-rich,
SH3 domain-binding protein that is localized to distinctive
regions of both the cell nucleus and the cytoplasm.
MATERIALS AND METHODS
Cells and Reagents—The bacterial expression vector pGEX-4T-1 was
purchased from Amersham Pharmacia Biotech. Glutathione-agarose
beads were obtained from Sigma Chemical Co. HEL, Namalwa, Jurkat,
and U937 cells were originally obtained from the American Type Cul-
ture Collection and cultured in RPMI 1640 medium (Flow Laborato-
ries), and COS and 293 cells were grown in Dulbecco’s modified Eagle’s
medium containing 10% heat-inactivated fetal calf serum (Imperial
Laboratories) at 37 °C in 5% CO2. All chemicals were Analar grade or
better (BDH), and all other reagents were purchased from Sigma unless
stated otherwise.
Glutathione S-Transferase Fusion Proteins—cDNA sequence encod-
ing the SH3 domains of PLC1, p85, c-src, n-src, c-fgr, p47phox, and
p67phox as glutathione S-transferase (GST) fusion proteins were gener-
ated and used as described previously (15, 16). Constructs were trans-
formed into Escherichia coli XL1-Blue, and expression of GST fusion
proteins was performed as described previously (26).
GST-SH3 Binding Assays and RNA-agarose Binding Assays—Affin-
ity matrices were prepared by immobilizing 25 g of fusion protein on
50 l of glutathione-agarose beads (Sigma). Cells were pelleted and
washed twice in phosphate-buffered saline. Cell pellets were solubilized
in lysis buffer (50 mM Tris, pH 7.5, 5 mM EGTA, 2% (v/v) Triton X-100,
75 mM NaCl, 0.5 mM phenylmethylsulfonyl fluoride) and clarified by
centrifugation at 14,000  g for 15 min at 4 °C. Cell lysate was mixed
with the GST-SH3 affinity matrices for 3 h at 4 °C. The beads were then
washed extensively in wash buffer (50 mM Tris, pH 7.5, 0.1% (v/v)
Triton X-100, 10% (v/v) glycerol). Binding proteins were eluted by
boiling in SDS-PAGE sample buffer, resolved by SDS-PAGE, and pre-
pared for microsequencing as described previously (15, 16).
Cells were also lysed into lysis buffer B (25 mM HEPES, pH 7.5, 150
mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 0.1% SDS, 10 g/ml leupep-
tin, 10 g/ml aprotinin) at 2 mg/ml for 30 min. The lysates were
centrifuged at 14,000 rpm, and 0.4 mg of the soluble material was added
to 50 l of a 50% suspension of poly(G)-, poly(A)-, or poly(U)-agarose
beads (Sigma) for 20 min. The beads were washed five times in lysis
buffer B, and the beads were resuspended in Laemmli lysis buffer for
SDS-PAGE and Western blotting. In some cases the beads were pre-
treated with 10 g of RNase for 10 min.
Sequencing and Cloning of 100-kDa SH3 Domain-binding Pro-
tein—A 100-kDa polypeptide that bound to the SH3 domains of p47phox
was purified from 109 Namalwa cells by SH3 affinity chromatography
as described above. The protein sample was separated by SDS-PAGE,
identified by Coomassie Blue staining, excised, and digested with Lys-C
in the gel slice. Peptides were extracted from the gel and separated by
tandem ion exchange and reverse phase high performance liquid chro-
matography using a Hewlett-Packard 1090M and diode array detection
system. Purified peptides were sequenced using fast cycle, automated
Edman chemistry on an Applied Biosystems 477A sequencer, modified
as described previously (27). Peptide sequences obtained from microse-
quencing were used to search the dbEST data base. Clone 27176 (ac-
cession number R13685) matched peptide LDEMEFNPVQQPXLNEK
and was obtained from the IMAGE consortium (28). DNA sequencing of
clone 27176 was carried out on an Applied Biosystems 373A DNA
sequencer using the Taq dye terminator cycle sequencing kit. Analysis
of the DNA sequence of clone 27176 revealed an open reading frame
that contained all the peptide sequences obtained from microsequenc-
ing. The cDNA N-terminal to the open reading frame was obtained by
5-PCR-RACE from human thymus cDNA (Marathon kit, CLON-
TECH). The extended open reading frame contained a methionine res-
idue within the correct context for the initiation of translation (51). The
PCR-derived cDNA and clone 27176 were ligated following digestion at
a unique restriction site, EspI.
Construction of DNA Expression Constructs Encoding myc-tagged
and GFP-tagged SNP70—For expression of SNP70 in COS7 cells, a
cDNA encoding residues 2–641 was amplified by PCR from the full-
length p100 cDNA using oligonucleotides containing an EcoRI site
(5-oligonucleotide) and NotI site (3-oligonucleotide). An EcoRI-NotI-
digested PCR fragment was subcloned into a pCDNA3 derivative,
which had been modified to contain an Myc epitope (MEQKLISEEDL)
followed by an in-frame EcoRI site. Expression of the Myc-tagged pro-
tein was driven from a cytomegalovirus promoter. The correct sequence
of the Myc-tagged construct was confirmed by DNA sequence analysis.
COS7 cells were transfected by electroporation. GFP-tagged SNP70
was constructed using overlapping recombinant PCR. Oligonucleotides
were designed to amplify the coding regions of SNP70 and enhanced
green fluorescent protein (CLONTECH) so that a second PCR reaction
enabled the in-frame gene fusion to be generated. A Kozak sequence
was added to the 5-translation start site of SNP70 to maximize expres-
sion. The SNP70-EGFP PCR product was cloned into the MSCVneo
vector (CLONTECH) as an EcoRI-XhoI fragment, and the sequence was
verified.
Western Blotting—Anti-peptide antibodies raised against the final 15
C-terminal residues from SNP70 were generated in rabbits and used for
Western blotting from cell lysates. SDS-PAGE-separated proteins from
105 cells were transferred to nitrocellulose filters, and, after blocking
with 5% non-fat milk powder for 1 h, the filters were overlaid with a
1:1000 dilution of anti-SNP70 in PBS containing 0.05% Tween 20 for
1 h. The filters were washed three times in PBS/Tween 20 and overlaid
with a peroxidase-conjugated goat anti-rabbit Ig (Bio-Rad). The bands
were detected using the ECL system (Amersham Pharmacia Biotech).
Images were scanned using a Microtek Scanmaker II, densitometry was
performed, and peaks were integrated using ScanAnalysis linked to an
Apple Macintosh Quadra computer.
Subcellular Fractionation—MDCK cells were subjected to hypotonic
shock for 5 min in 10 mM Tris, pH 7.4, plus 1 mM MgCl2 followed by
Dounce homogenization in the presence of protease inhibitors (Mixture
set III, Calbiochem). Centrifugation at 1000  g produced a nuclear
pellet, and centrifugation of the post-nuclear supernatant at 100,000 
g for 30 min produced a particulate pellet consisting mainly of the
membranous components of the cells and a cytosolic supernatant.
Immunofluorescence—Cells were grown for 24 h on glass coverslips
and fixed in 4% paraformaldehyde (Fluka) in PBS for 10 min. After
three washes in PBS the cells were permeabilized by immersion in 0.2%
Nonidet P-40 in PBS for 5 min. Staining was performed by a 1:200
dilution of rabbit anti-SNP70 in PBS plus 2% BSA for 45 min, followed
by a 1:100 dilution of FITC-labeled goat anti-rabbit Ig with three
washes in PBS between antibodies. After an additional three washes in
PBS the cells were mounted in Citifluor and viewed using a Zeiss
axioplan microscope equipped with epifluorescence. In some experi-
ments cells were viewed using a Zeiss Axiovert microscope equipped
with Biovision digital confocal microscopy software (Improvision Ltd.,
Warwick, UK). Double-immunofluorescence was performed using
monoclonal antibodies to the pre-mRNA splicing factors SC35 and U2B
in combination with anti-SNP70 antibodies followed by a mix of FITC-
labeled goat anti-rabbit Ig and TRITC-labeled goat anti-mouse Ig. The
FITC-labeled goat anti-rabbit Ig and TRITC-labeled goat anti-mouse Ig
secondary antibodies were cross-absorbed against mouse Ig and rabbit
Ig, respectively, to prevent cross-species Ig reactivity.
Northern Blotting—The SNP70 full-length cDNA was cut out of the
pCDNA3.1 myc-tagged vector using EcoRI and NotI (Life Technologies,
Inc.), the 2-kb insert was gel-purified using a QIAquick kit (Qiagen) and
radiolabeled to a specific activity of 2  109 dpm/mg using a Re-
diPrime random prime labeling kit (Amersham Pharmacia Biotech). A
Multiple tissue Northern blot containing poly(A) mRNA isolated from
various human tissues (CLONTECH) was prehybridized with
RapidHyb (Amersham Pharmacia Biotech) for 30 min at 60 °C. The
unincorporated nucleotides ([32P]dCTP) were removed using a nick spin
column (Bio-Rad), and the denatured probe was added to the RapidHyb
buffer. After overnight hybridization at 60 °C, the blot was washed at
high stringency (twice in 2 SSC/0.1% (w/v) SDS for 20 min each and
once in 0.1 SSC/0.1% (w/v) SDS for 20 min). The blot was exposed for
2 h at 70 °C using Hyperfilm-MP (Amersham Pharmacia Biotech).
The blot was subsequently stripped by adding boiling 1% (w/v) SDS and
allowing to cool to room temperature. The stripping was confirmed by
overnight autoradiography at70 °C and re-probed using a RediPrime-
labeled (as before) actin probe supplied with the Multiple tissue blot.
Immunoelectron Microscopy—Cells were plated onto glass coverslips,
extracted with 0.5% Nonidet P40 in the presence of phalloidin and taxol
(Sigma), and processed for immunoelectron microscopy essentially as
described previously (29). Briefly, after washing, the cells were fixed in
2% paraformaldehyde in PBS (Fluka) and then preincubated in Tris
saline containing 100 mM lysine, 2% BSA, 0.5% Tween 20, pH 8.0, for 20
min. After three further washes, the cells were labeled for 2 h with
rabbit anti-SNP70 (1:100) followed by incubation with a 1:20 dilution of
anti-rabbit Ig-colloidal gold (Sigma Chemical Co.) for 4 h. All antibodies
were diluted in Tris-lysine BSA buffer. The cells were fixed in 2%
glutaraldehyde in 0.1 M and pH 6.8 for 1 h at room temperature and
then stored in Pipes buffer at 4 °C, post-fixed in 0.5% Os5O4 in Pipes
buffer for 15 min, and then processed as described previously (29).
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Micrographs were taken on a Phillips CM10 electron microscope oper-
ating at 80 kV.
Extraction of SNP70 from Cell Nuclei—Cells were plated onto glass
coverslips overnight and subjected to one of the following extraction
procedures: CSK buffer (10 mM Pipes, pH 6.8, 300 mM sucrose, 100 mM
NaCl, 3 mM MgCl2, 1 mM EGTA, 1% Nonidet P-40) for 40 min on ice;
CSK buffer plus 10 g/ml RNase A; CSK buffer plus 500 units/ml
DNase I for 40 min at 37 °C; CSK buffer plus 0.25 M ammonium sulfate
for 40 min on ice; CSK buffer plus 2 M NaCl for 40 min on ice. 4-(2-
Aminoethyl)benzenesulfonyl fluoride, 1 mM, was included in all buffers
to limit proteolytic digestion. After extraction the cells were washed in
ice-cold CSK buffer, fixed, and stained as described above. Alterna-
tively, the cells were grown in 60-mm Petri dishes, and after extraction
the cells were lysed directly into SDS sample buffer, boiled for 5 min,
and subjected to SDS-PAGE for Western blotting.
RESULTS
SH3 Domain binding Proteins from a B Cell Line—Namalwa
cells were lysed into Triton X-100-containing buffer, and after
centrifugation of insoluble material the lysates were incubated
with immobilized fusion protein constructs of GST-SH3 do-
mains. Fig. 1 shows that the Namalwa cell proteins, which
bound to the tandem N- and C-terminal SH3 domains of
p47phox (p47phox N/C) or the SH3 domain of PLC1, gave dis-
tinct profiles. Both domains bound a polypeptide of 60 kDa.
Polypeptides of 70 and 75 kDa associated only with p47phox
N/C, and a polypeptide of about 90 kDa bound to both PLC
and p47phox N/C. There was an additional prominent band
detected at about 100 kDa, which also bound to the immobi-
lized p47phox N/C-SH3 domain-containing construct (arrow).
This 100-kDa protein did not bind to beads alone, to GST-
immobilized beads, or to the SH3 domain of PLC1. Larger
quantities of the 100-kDa band were prepared from 109 cells
and purified by binding to p47phox N/C SH3 domain followed
by SDS-PAGE. The band was excised and subjected to
microsequencing.
Cloning and Sequencing of SNP70—Ten peptides were de-
rived from microsequencing of the 100-kDa polypeptide bound
to p47phox SH3 domain (Fig. 2). Data base searching revealed
several expressed sequence tags with similar identity to that of
the 90-kDa protein-derived peptides. The corresponding clones
were obtained from the IMAGE consortium. The longest of
these clones was clone 27176 (GenBankTM accession number
R13685) with an open reading frame that contained all of the
peptide sequences derived from protein microsequencing. The
5-end was obtained by RACE PCR and contained a methionine
residue in the correct context for the initiation of translation.
The complete amino acid sequence of SNP70 is shown in Fig. 2.
The polypeptide has 641 residues, and the predicted amino acid
sequence encodes a protein with a molecular mass of 69,997
kDa. The polypeptide has a theoretical pI of 8.28 and contains
an unusually high proportion of proline residues (18.6%). It is
possible that this could account for its aberrant migration
properties on reducing SDS-PAGE, where it runs with an ap-
parent molecular mass of about 100 kDa. The amino acid
sequence reveals several possible functional regions in SNP70.
Four putative nuclear localization sites are found in the N-
terminal half of the protein (residues 2–39, 78–83, 226–233,
and 314–322). The C-terminal region contains proline-rich se-
quences that are likely to be the SH3 domain binding se-
quences (residues 410–531). In addition there is a potential
profilin binding sequence in the C-terminal half (residues 461–
489). No membrane signal or other binding motifs were de-
tected. Data base searching revealed no homology with any
other known protein. On the basis of this and the following
work, we have termed this polypeptide SNP70, for SH3 domain
binding Protein, 70 kDa.
Generation of Antibodies against SNP70—To gain more in-
formation about the function of SNP70, rabbit anti-peptide
antibodies were raised against the 15 C-terminal residues.
Western blotting using anti-peptide antisera revealed the de-
tection of a single band that runs at about 100 kDa on reducing
SDS-PAGE (Fig. 3A), whereas preimmune sera from the same
animals gave no such band. Confirmation that the anti-peptide
antibodies recognized the cloned protein was obtained by trans-
fection of myc-tagged SNP70 cDNA into COS7 cells. Immune
precipitation using anti-myc antibodies or anti-SNP70 antibod-
ies followed by Western blotting with anti-SNP70 antibodies
gave identical results showing the presence of a polypeptide of
about 90 kDa (Fig. 3B). Thus SNP70 runs with a higher ap-
FIG. 1. Profile of SH3 domain-binding proteins. GST-SH3 fusion
proteins were immobilized to glutathione beads as described under
“Materials and Methods.” Lysates from Namalwa cells were adsorbed to
the beads, and the bound proteins were separated by SDS-PAGE under
reducing conditions followed by Coomassie Blue staining. The 90-kDa
protein, which was analyzed further, is denoted with an arrow. M,
markers; BEADS, glutathione beads alone; GST, glutathione beads
with immobilized GST; p47NC, glutathione beads with immobilized
with the tandem N- and C-terminal SH3 domains of p47phox.
FIG. 2. Complete predicted amino acid sequence of SNP70. The
peptide sequences derived from microsequencing of the SH3 domain-
binding protein are shown underneath. These sequence data are avail-
able from the GenBankTM under accession number AF118023.
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parent molecular weight than would be predicted from the
primary sequence. The reason for this is presently unknown
but may be related to its high proline content. Examination of
a number of cell lines showed that SNP70 was expressed in all
cells tested, which included B cells, T cells, monoblastoid cells,
reticuloendothelial cells, and fibroblasts (Fig. 3A; data not
shown).
Selectivity of SNP70 Binding to SH3 Domains—The binding
of SNP70 to a panel of 12 immobilized SH3 domains was
performed, and the association was detected by immunoblot-
ting (Fig. 4). Initial studies indicated that SNP70 bound selec-
tively to the N-terminal SH3 domain derived from the NADPH
oxidase component p47phox, and to a construct containing both
the N- and C-terminal SH3 domains of p47phox. Longer expo-
sures showed that SNP70 bound to the SH3 domains derived
from p85 and c-src in addition to p47phox (Fig. 4B). Direct
comparison of binding activities demonstrated that SNP70
bound preferentially to the p47phox N-terminal SH3 domain
and more weakly to the p85 and c-src SH3 domains (3 and 6%,
respectively, of p47phox binding as assessed by scanning densi-
tometry). No binding was detected to the SH3 domains derived
from GAP, GRB2, itk, n-src, abl, PLC1, fgr, the C-terminal
SH3 domain of p47phox, or either the N- or C-terminal domains
of p67phox (Fig. 4, A and B).
Tissue Distribution of SNP70—All cell lines tested were
positive for SNP70 by Western blotting (Fig. 3A; data not
shown). Northern blotting experiments on a number of human
tissues were performed to examine the tissue expression of
SNP70 mRNA. A single band of 3 kb corresponding to the
SNP70 message was detectable on all tissues examined (Fig.
5A); however, longer exposures showed the presence of further
transcripts at 4 and 5 kb (data not shown). The highest level
of mRNA could be seen in the heart, with pancreas, kidney,
skeletal muscle, placenta, and brain also exhibiting compara-
tively high levels of message. The SNP70 message was lowest
in liver and lung, where only a faint band was detected. West-
ern blotting was also performed on human tissue extracts.
Consistent with Northern blotting, heart tissue showed the
highest levels of SNP70, with skeletal muscle, ovary, testis,
brain, and kidney also giving a strong band (Fig. 5B, upper
panel). Lung and liver had no detectable SNP70 protein, again
consistent with the low level of message found in Northern
blots. Fig. 5B lower panel shows a Coomassie Blue-stained gel,
indicating that loadings for the Western blots were approxi-
mately equal.
Nuclear Localization of SNP70—Preliminary immunofluo-
rescence experiments in a number of cell types revealed nu-
clear staining of T lymphoid cells, B lymphoblastic cells, mono-
cytic cells, fibroblasts, and epithelial cells (data not shown).
MDCK cells were chosen for further investigation, because
they are relatively large cells with prominent nuclei and thin
cytoplasm, which allows good intracellular localization at the
light microscope level. Antibody staining of formaldehyde-
fixed, permeabilized cells revealed that SNP70 was localized
prominently in the nucleus and had a granular appearance
when viewed at high magnification, which was even more ap-
parent when digital confocal microscopy was used (Fig. 6, a and
l). There was some diffuse staining present in the cytoplasm of
interphase cells. Double staining with propidium iodide
showed that SNP70 did not co-localize specifically with DNA,
because it was excluded from nucleoli where DNA staining was
strongest (Fig. 6, a–c). The localization of SNP70 in dividing
cells was different from that of interphase cells. In prophase
cells where DNA condensation had just been initiated, the
nuclear SNP70 staining became more diffuse throughout the
cell (Fig. 6, d–f, arrows), and in metaphase or anaphase cells
SNP70 was distributed throughout the cytoplasm but excluded
from the condensing chromatids (Fig. 6, g–i, arrows). To exam-
ine whether the cloned gene product had a similar localization
to endogenous SNP70, cDNA for SNP70 was microinjected into
MDCK cells and 24 h later the cells were processed for immu-
nofluorescence. Immunofluorescence microscopy revealed that
the recombinant protein was localized predominantly in the
nucleus, however, there was some excess protein in the cyto-
plasm, suggesting that the nuclear transport mechanism had
been saturated by the overproduction of SNP70 (Fig. 6, j and k).
Digital confocal microscopy revealed that SNP70 had a granu-
lar, heterogeneous distribution within the nucleus (Fig. 6l).
Extraction of SNP70 from Cell Nuclei—The intracellular
localization of SNP70 suggested that it did not bind directly or
indirectly to DNA in the nucleus, because its immunofluores-
cence staining profile did not exactly coincide with propidium
iodide staining. To investigate this further the biochemical
characteristics of SNP70 association with cell nuclei were stud-
ied by the use of a variety of extraction procedures. SNP70
nuclear localization was resistant to extraction with 1% Non-
idet P40 in cytoskeleton buffer for 40 min, a procedure that
extracts several nuclear proteins such as proliferating cell nu-
clear antigen (data not shown; Fig. 7, a and b). Thus SNP70
was not a soluble nuclear protein. SNP70 nuclear localization
was also resistant to digestion with DNase I under conditions
that removed virtually all the DNA from the nucleus (Fig. 7, c
and d). In contrast, substantial amounts of SNP70 were ex-
tracted from nuclei by treatment with RNase A (Fig. 7, e and f),
suggesting a partial interaction with nuclear RNA. Extraction
with either 2 M sodium chloride (Fig. 7, g and h) or 0.25 M
ammonium sulfate (Fig. 7, i and j) resulted in almost total loss
of SNP70, although the latter three conditions had no effect on
nuclear DNA staining. The differential extraction profiles of
DNA and SNP70 demonstrated that this protein did not closely
associate with DNA. Additional experiments also revealed that
the cytosolic SNP70 in mitotic cells was readily removed by a
brief Nonidet P-40 extraction (data not shown). Quantitation
revealed that Nonidet P40-treated or DNase I-treated cells
retained greater than 90% of SNP70 whereas 64% was solubi-
lized by RNase, 77% solubilized by 2 M NaCl, and 89% was
solubilized by 0.25 M ammonium sulfate (data not shown). The
preceding experiments were performed in cells that had been
extracted with detergent prior to further biochemical fraction-
ation. To further assess the association of SNP70 with the
nucleus, cells were subjected to hypotonic shock followed by
FIG. 3. Characterization of antibodies against SNP70 and its
cellular distribution. A, total SDS-PAGE extracts from Namalwa,
COS, or 293 cell lines were immunoblotted using either anti-SNP70
peptide anti-serum or animal-matched preimmune serum. I, immune
anti-peptide sera; P, animal-matched preimmune serum. B, cells trans-
fected with myc-tagged SNP70 were lysed and immunoprecipitated
with anti-myc, followed by immunoblotting with either anti-myc (lanes
1 and 2) or anti-SNP70 antibodies (lanes 3 and 4).
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Dounce homogenization. A low speed spin produced isolated
nuclei with attached cytoskeletal components whereas a high
speed spin of the post-nuclear supernatant produced a partic-
ulate fraction consisting mainly the membranous components
of the cells and a cytosolic fraction. Western blotting revealed
that SNP70 was predominantly associated with the nuclear
fraction, with a minority associated with the membranous frac-
tion. No detectable SNP70 was found in the cytosol (Fig. 8A). In
all cases preimmune sera from the same animals gave minimal
background labeling (data not shown). Several SH3 domain-
binding proteins, which shuttle in and out of the nucleus, bind
to RNA, therefore, we tested whether SNP70 bound RNA im-
mobilized on beads. Fig. 8B shows that SNP70 from mamma-
lian cells bound to poly(G)-agarose beads but did not bind to
poly(U)- or poly(A)-agarose beads. The association of SNP70
binding to poly(G)-agarose beads was abolished if the beads
were pretreated with RNase, showing that the binding was
RNA-dependent (Fig. 8B).
Nuclear SNP70 Co-localizes with Pre-mRNA Splicing Fac-
tors—Immunofluorescence showed that the nuclear staining of
SNP70 was granular and, upon close examination using digital
confocal microscopy, was localized to 20–30 distinct speckles
within the nucleus, reminiscent of the distribution of
pre-mRNA splicing factors (30). To determine whether SNP70
associated with these spliceosome factors, double immunofluo-
rescence was performed using antibodies to SNP70 and the
pre-mRNA splicing factors SC35 and U2B (31, 32). The stain-
ing patterns of SC35 and U2B showed the expected localiza-
tion to nuclear speckles, and double-immunofluorescence ex-
periments showed strong co-localization of SNP70 with both
the pre-mRNA splicing factors SC35 (Fig. 9, a and b) and U2B
(Fig. 9, c and d). Treatment of cells with the RNA polymerase
II inhibitor -amanitin induces aggregation of splicing factor-
containing speckles (30). After 60-min treatment the nuclear
speckles containing SC35 and U2B had fused to form much
larger domains within the nucleus (Fig. 9, f and h). SNP70
FIG. 4. Selectivity of SNP70 binding
to SH3 domains. A, the binding of
SNP70 from Namalwa cell lysates to a
panel of immobilized GST-SH3 domain
fusion proteins was performed as de-
scribed for Fig. 1, and the bound SNP70
was detected by Western blotting as de-
scribed for Fig. 3. B, longer exposure of
SH3 domains binding profile of selected
SH3 domains. C, comparison of SNP70
binding to c-src, p85, and p47N SH3 do-
mains. Upper panel, Western blot of
SNP70; lower panel, Coomassie Blue
staining of immobilized SH3 domain fu-
sion proteins.
FIG. 5. A, Northern blotting of SNP70 on human tissues. RNAs from
a panel of human tissue (CLONTECH) were run on an acrylamide gel
and probed with a full-length SNP70 probe. The lower panel shows the
blot stripped and reprobed from -actin. B, Western blotting of SNP70
in a number of human tissues. The lower panel shows a parallel Coo-
massie Blue-stained gel as a loading control.
FIG. 6. Double fluorescence of SNP70 and DNA in MDCK cells.
Cells were stained with anti-SNP70 (a, d, g, j, l) or propidium iodide (b,
e, h). a–c, interphase cells showing nuclear distribution of SNP70 but
exclusion from nucleoli. d–f, early metaphase cell showing fragmenta-
tion of nuclear SNP70 (arrows) and condensation of DNA. g–i, late
anaphase cells showing cytoplasmic distribution of SNP70 (arrows) and
its exclusion from condensing chromosomes. j and k, nuclear localiza-
tion of overexpressed recombinant SNP70. l, a digital confocal image of
a 1-m optical slice of SNP70 in an interphase cell showing the gran-
ularity of nuclear staining. Bars, 20 m.
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co-localized with these factors, showing a similar redistribution
to the fused speckles (Fig. 9, e and g). Not only was there
evident co-localization in the nucleus, the size and intensity of
the pre-mRNA splicing factor speckles correlated closely with
that of SNP70. Specificity control experiments using the anti-
mouse secondary antibodies with rabbit primary antibodies
and vice versa showed only faint background fluorescence (data
not shown).
Association of Cytoplasmic SNP70 with Vimentin—When
cells were fixed in methanol, there was clear localization of
SNP70 to a perinuclear localization (Fig. 10, k and l), which
was not as prominent when cells were fixed in formaldehyde.
To confirm that this was not an artifact of spurious antibody
cross-reaction, the intracellular localization of a GFP-tagged
SNP70 was investigated. Cells were transfected with GFP-
SNP70, and its localization was detected using fluorescence.
GFP-SNP70 showed two distinct localizations. There was lo-
calization to the speckles as seen with antibody staining (Fig.
10b, arrows). In addition there was a perinuclear localization,
suggesting association with a matrix surrounding the nucleus
(Fig. 10a, arrowhead). This double localization to perinuclear
matrix and nuclear speckles can be found in the same cell when
different focal planes are studied (Fig. 10c, arrows; Fig. 10d,
arrowheads). In some cells the nuclear speckles and perinu-
clear matrix staining can be seen in the same focal plane (Fig.
10e, arrow and arrowhead). Cells transfected with GFP alone
show an even fluorescence throughout the cell (Fig. 10f). The
perinuclear GFP-SNP70 co-localized in part with vimentin
staining of intermediate filaments, although GFP-SNP70 dis-
tribution was not as extensive in the cytoplasm of the cells as
vimentin, being more concentrated around the nucleus (Fig. 10,
g and h, arrows). When cells were treated with colchicine, the
vimentin-containing filament system collapsed around the nu-
cleus (Fig. 10i). GFP-SNP70 co-distributed with vimentin in
these treated cells to an even tighter perinuclear localization
(Fig. 10, i and j, arrowheads). Untransfected, methanol-fixed
cells double stained using anti-SNP70 and anti-vimentin
showed a similar co-localization demonstrating that the fila-
mentous perinuclear distribution of SNP70 was not an artifact
of GFP tagging (Fig. 10, k and l, arrows). Perinuclear matrix
co-localization could not be detected in formaldehyde-fixed,
Triton X-100-extracted cells, presumably because formalde-
hyde destroyed the association. Pre-immune sera from the
FIG. 7. Extraction of SNP70 from nuclei. Cells grown on cover-
slips were treated with 1% Nonidet P-40 (a, b), DNase I (c, d), RNase A
(e, f), 2 M NaCl (g, h), or 0.25 M ammonium sulfate (i, j). SNP70 in the
treated cells was detected by staining with anti-SNP70 (a, c, e, g, i) and
DNA detected by staining with propidium iodide (b, d, f, h, j) as de-
scribed under “Materials and Methods.” Bar, 20 m.
FIG. 8. Subcellular fractionation of SNP70 and RNA binding.
A, whole cell lysates or lysates from cells subjected to fractionation into
nuclear, post-nuclear membranous, and cytosolic fractions followed by
SDS-PAGE were immunoblotting for SNP70. B, lysates from MDCK
cells were incubated with poly(G)-, poly(U)-, or poly(A)-agarose beads,
and the SNP70 bound to the beads was detected by Western blotting. In
lanes 4–6 the oligonucleotides beads were pretreated with RNase as
specificity controls.
FIG. 9. Double immunofluorescence of SNP70 (a, c, e, g) and
the pre-mRNA splicing factors SC35 (b, f) and U2B (d, h). In
panels a–d the cells were fixed in 3.7% formaldehyde and permeabilized
with 0.5% Nonidet P-40. In panels e–h the cells were pretreated with 5
g/ml -amanitin for 60 min prior to fixation. The cells were subjected
to digital confocal immunofluorescence microscopy and representative
images are shown. Bar, 20 m.
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same animals gave only low background fluorescence (data not
shown). To gain further insight into the cellular function of
SNP70, immunoelectron microscopy using anti-SNP70 plus
gold-conjugated goat anti-rabbit Ig was performed on fixed,
permeabilized cells. Intermediate filaments connecting with
the nucleus are apparent (Fig. 11). Immunogold labeling of
these intermediate filaments could be clearly detected and
appeared to be direct (Fig. 11). The majority of gold particles
were found either as singlets on intermediate filaments or
clusters of up to five particles on other perinuclear detergent-
insoluble structures (Fig. 11). Gold particles also labeled the
nuclear periphery but only in regions devoid of nuclear mem-
brane (Fig. 11). No gold particles were found in association with
intracellular membrane vesicles (data not shown), and a max-
imum of ten gold particles in total were found randomly dis-
persed in regions similar to those shown in Fig. 11 in cells
incubated with control antibody (not shown).
DISCUSSION
More than 80 SH3 domain-containing proteins have now
been described. The majority of these proteins fall into the
categories of signaling proteins or proto-oncogenes, the arche-
type being pp60c-src, and it has been shown that the presence of
the SH3 domain of this protein is essential for DNA synthesis
induced by platelet-derived growth factor and epidermal
growth factor (33, 34). Several cytoskeletal proteins also con-
tain SH3 domains, for example myosin I and -spectrin, and
these domains may be involved in the intracellular localization
of proteins (35). A third category of SH3 domain-containing
proteins are the components of the NADPH oxidase system of
phagocytes. The SH3 domains of the cytoplasmic components
p47phox and p67phox interact with the cytoplasmic tail of the
membrane component p22phox, and this subunit assembly
results in an active holoenzyme (15, 16, 25, 36). Less is known
about the function of SH3 domain-binding proteins. A number
of these are linked to intracellular signaling complexes found
near the plasma membrane, for example, proline-rich se-
quences of SOS bind to the SH3 domains of Grb2, and this leads
to the activation of ras and is therefore required for growth
factor signaling (37). Several SH3 domain-binding proteins
have been identified in the activation pathway of small GTP-
binding proteins; the first molecule identified as an SH3 do-
main-binding protein, 3BP1, is a rasGAP (38), and dynamin,
which binds to the SH3 domain of phosphatidylinositol kinase,
is a GTPase (14).
In most cases SH3 domain-binding proteins are located ei-
ther at the plasma membrane or in the cytoplasm, commonly
near the plasma membrane; however, more recently a family of
other SH3-binding proteins with a different cellular localiza-
tion has been described. Heteroribonucleoprotein K is an RNA-
binding protein that also interacts with the SH3 domain of vav,
FIG. 10. Localization of SNP70 in HEK293 cells. a–f, subcellular
localization of GFP-SNP70. GFP-SNP70 was localized to a perinuclear
region (a) or nuclear speckles (b). This distribution could be seen in the
same cell when focused either through the midpoint of the nucleus (c,
arrows) or slightly above the nucleus (d, arrowheads). The two distinct
distributions can also be seen in the same plane of focus in the same cell
(e, arrow, arrowhead). Control GFP shows a diffuse distribution (f). g–l,
co-localization of SNP70 and vimentin. g and h, double labeling of
GFP-SNP70 and vimentin (h) showing co-localization (arrows). i and j,
double labeling of GFP-SNP70 and vimentin in colchicine-treated cells,
showing co-distribution of SNP70 with collapsed vimentin filaments
around the nucleus (arrowheads). k and l, indirect immunofluorescence
of SNP70 (k) and vimentin (l) in HEK293 cells, showing co-localization
(arrows). Bar, 20 m.
FIG. 11. Triton X-100-extracted MDCK cell labeled with rabbit
anti-SNP70 followed by colloidal gold-conjugated goat-anti-rab-
bit Ig. Clear labeling is seen on nuclear-associated intermediate fila-
ments. The nuclear periphery (devoid of any visible membrane) is
sparsely labeled. Gold particles are associated with some apparently
nuclear-associated cytoplasmic material. Magnification, 63,000. Bar,
200 nm.
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which may link receptor events with the cell nucleus (39). A
protein recently identified as a target for c-src during mitosis,
SAM68, is an RNA-binding protein that associates with a num-
ber of SH3 domains using several of its proline-rich (24, 40, 41).
SAM68 co-localizes with nck in the cell nucleus (42), thus there
appears to be a subset of SH3 domain-binding proteins that
have some association with the nucleus or nuclear material.
The work reported here describes a protein, SNP70, that is
mainly localized within the nucleus, which also binds to SH3
domains and poly(G)-containing RNA, but does not belong to
this former RNA-binding protein family. Although an extensive
survey of cells has not been performed, the protein appears to
be ubiquitous and is present on all representatives of epithelial,
fibroblastic, and hemopoietic cells tested to date and in all
tissues investigated. The primary sequence of SNP70 shows
that it contains a number of putative functional domains.
SNP70 contains several potential nuclear localization signal
sequences, and this is consistent with immunofluorescence ex-
periments. The C-terminal half is highly proline-rich and con-
tains a number of potential SH3 domain-binding sequences,
and there is also a sequence conforming to profilin-binding
sites. Using a panel of SH3 domains we found that SNP70
bound strongly to the tandem SH3 domains of p47phox and to
the N-terminal SH3 domain of p47phox, and more weakly to the
SH3 domains from c-src and p85. p47phox is a phagocyte-
restricted protein and is normally found in the cytosol, con-
trasting with SNP70, which appears to be ubiquitous and pre-
dominantly associated with the nucleus, and so it is unlikely
that p47phox is the normal ligand for SNP70. However, the p85
subunit of phosphatidylinositol 3-kinase and the tyrosine ki-
nase c-src are also ubiquitous proteins and may represent bona
fide binding partners for SNP70. The stronger binding to
p47phoxN may be a result of the structural characteristics of
this SH3 domain and have no physiological relevance; however,
it is possible that there is an as yet unidentified ubiquitous
SNP70 ligand whose SH3 domain is structurally similar to that
of p47phox present in either the cytoplasm or nucleus of cells.
Recently Komuro et al. (43) have described a novel nuclear
protein NpwBP. This protein interacts with the WW domain of
another nuclear protein, Npw38, via proline-rich sequences
and is found in the nucleus. Sequence comparison shows that
SNP70 and NpwBP are identical. The C-terminal proline-rich
sequences of SNP70/NpwBP, which bind to the WW domain of
Npw38 also fit with both classic type I and type II SH3 binding
sequences, thus SNP70 has the potential to bind to SH3 do-
mains either in forward or reverse orientations (22, 43). It is
also possible that these domains may compete for binding
within the cell or be differentially regulated.
We have found that cell-derived SNP70/NpwBP has the abil-
ity to bind to poly(G)-containing beads, suggesting an affinity
for RNA or single-strand DNA. Komoro et al. have also found
that in vitro translated SNP70/NpwBP binds selectively to
poly(G) oligonucleotides and G-rich single-strand DNA (43).
These data and the additional results showing that SNP70 can
be partially extracted from cells by RNase treatment indicate
that it is likely to be an RNA-binding protein. Although SNP70/
NpwBP does not have any homologies with other RNA-binding
proteins such as SAM68 or heteroribonuclear proteins, there
appears to be some specificity in its RNA binding because
SPN70/NpwBP does not associate with poly(U)- or poly(G)-
oligonucleotides. This RNA-binding property appears to be im-
portant for its nuclear localization, because RNase treatment
dramatically reduced nuclear staining of SNP70. Our experi-
ments additionally indicate that nuclear localization is not
DNA-dependent, because SNP70/NpwBP is not extracted un-
der conditions where DNA is removed. Immunofluorescence
experiments demonstrated strong nuclear staining of SNP70
and exclusion from the nucleolus. This localization changes as
cells undergo mitosis, and in fully mitotic cells SNP70 appears
as a protein distributed throughout the cytoplasm. Further
extraction and subfractionation experiments showed that
SNP70 was associated with isolated nuclei and associated cy-
toskeletal elements, was resistant to DNase treatment or ex-
traction in non-ionic detergents, but was solubilized by high
salt or ammonium sulfate, treatments commonly used to iso-
late intermediate filaments and nuclear matrix material (44).
These data suggest that SNP70 does not associate directly with
DNA but associates with a matrix-like component of the cells.
Double immunofluorescence revealed that SNP70 co-localized
with pre-mRNA splicing factors in distinct nuclear speckles,
which appear to correspond to interchromatin granule clusters
(45). Like SNP70, splicing factors in the speckles are resistant
to extraction with non-ionic detergent or DNase I treatment,
indicating an association with structural components of the
nucleus (45). Taken together with our finding that in the cyto-
plasm SNP70 associates with the intermediate filament pro-
tein vimentin, it is tempting to speculate that nuclear SNP70 is
either a structural component of the spliceosome or associates
with structural components of the spliceosome. Komuro et al.
(43) suggested that SNP70/NpwBP may be involved in the
mRNA machinery of cells. Our results showing partial extrac-
tion by RNase treatment, co-localization with splicing factors,
and binding to poly(G)-containing oligonucleotides are consist-
ent with this, and the functional changes in the distribution of
both splicing factors and SNP70/NpwBP upon RNA polymerase
II inhibition with -amanitin add even more credence to the
involvement of SNP70/NpwBP in mRNA processing. We have
been unable to show co-immunoprecipitation of SNP70 with
SC35, U2B, p85, or c-src under a number of different extrac-
tion conditions (data not shown). However, SNP70 is largely
insoluble under conditions that normally allow co-precipitation
(e.g. low concentrations of Triton X-100), and the conditions
necessary to extract sufficient SNP70 may be too stringent to
maintain any intermolecular interaction after lysis. Indeed
SC35 dissociates readily from the spliceosome and is not de-
tected in spliceosome preparations (46). Similarly, SH3 domain
affinities are commonly in the low micromolar range, which
may not be maintained through immune precipitation proce-
dures. Binding of a proline-rich sequence can occur when a cell
lysate is exposed to immobilized SH3 domain in vitro, because
this is presented in high excess, thus forcing the reaction to-
ward binding.
Higher power examination by immunoelectron microscopy
revealed that SNP70 associated with intermediate filaments,
especially those surrounding the nucleus. The observation, that
the relocation of SNP70 from a perinuclear to a cytoplasmic
distribution coincides with the onset of mitosis and, therefore,
coincides with the breakdown of nuclear-associated intermedi-
ate filaments and the nuclear envelope, is also consistent with
an association with a matrix component. RNA-cytoskeletal in-
teractions have been shown to influence the transport, anchor-
ing, and translation of mRNA (47, 48), and the same may be
true for transcription and nascent pre-mRNA. The subcellular
distribution and sequence motifs suggest that SNP70 may be a
link between signaling or the cytoskeleton and transcriptional
activity. The internal nuclear matrix is surrounded by the
lamina/pore complex, which is connected to the intermediate
filament system (49), and replication sites and transcription
sites are organized by nuclear matrix-intermediate filament
scaffolds (reviewed in Ref. 50). Because SNP70/NpwBP can be
extracted by high salt and ammonium sulfate, it is unlikely to
be a structural protein of the nuclear matrix-intermediate fil-
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ament scaffold; however, its localization suggests that it may
be associated with these structures. The fact that SNP70 is a
ubiquitous protein suggests it plays an essential role in cell
regulation. SNP70 may thus be involved in cell proliferation or
mRNA splicing events, making this protein a potentially useful
therapeutic target for diseases such as cancer and chronic
inflammation.
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